Resveratrol attenuates inflammation through tristetraprolin expression in human hepatocytes

Authors: Akhi Moni, Asif Iqbal and Md Jamal Uddin


J Adv Biotechnol Exp Ther.
Scopus Indexed
2018; 1(3):78-82
DOI: 10.5455/jabet.2018.d14

Abstract: Resveratrol (Resv), a polyphenolic compound have the anti-inflammatory and antioxidant effects. Tristetraprolin (TTP) destabilizes mRNAs of pro-inflammatory cytokines. However, it was not clear how Resv exerts anti-inflammatory effects on hepatocytes. In this study, we used human hepatoma cell line (HepG2 cells) and analyzed samples using qRT-PCR. Resv increases TTP expression in hepatocytes. Resv attenuates LPS-induced inflammation through TTP expression in hepatocytes. In TTP
deficient hepatocytes, LPS failed to attenuate TNFα, iNOS, and IL-6 mRNA expression whereas TTP level was still decreased. Our results suggest that Resv may attenuate inflammation in hepatocytes through TTP induction at least in part. This novel Resv-TTP signaling pathway provides new possibilities
for the treatment of inflammatory diseases in liver.

Pin It on Pinterest